BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2209643)

  • 1. Treatment of patients with sarcoma of the uterus.
    Bokhman JV; Yakovleva IA; Urmanchejeva AF
    Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with sarcoma of the uterus].
    Bokhman IaV; Urmancheeva AF
    Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of early uterine sarcomas: disentangling adjuvant modalities.
    Zagouri F; Dimopoulos AM; Fotiou S; Kouloulias V; Papadimitriou CA
    World J Surg Oncol; 2009 Apr; 7():38. PubMed ID: 19356236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and pathologic study of 34 sarcomas of the uterus.
    Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
    Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcoma 2008.
    Lin JF; Slomovitz BM
    Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and surgical therapy of uterine sarcoma.
    Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
    Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of uterine sarcomas (author's transl)].
    Stegner HE
    Pathol Res Pract; 1980 Oct; 169(2):120-6. PubMed ID: 7443570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
    Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
    Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure.
    Dafopoulos A; Tsikouras P; Dimitraki M; Galazios G; Liberis V; Maroulis G; Teichmann AT
    Arch Gynecol Obstet; 2010 Sep; 282(3):293-300. PubMed ID: 20502905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
    Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
    Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma.
    Oláh KS; Dunn JA; Gee H
    Br J Obstet Gynaecol; 1992 Jul; 99(7):590-4. PubMed ID: 1326319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.
    Visnovsky J; Kudela E; Slavik P; Krkoska M; Buocik P; Szepe P; Danko J
    Neuro Endocrinol Lett; 2015; 36(8):750-7. PubMed ID: 26921575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.